Cell Source, Inc.
CLCS
$0.82
$0.000.00%
OTC PK
| 03/31/2025 | 09/30/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -38.18% | -2.10% | -30.78% | -30.78% | -27.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.26% | -16.46% | 31.83% | 31.83% | -19.60% |
| Operating Income | 12.26% | 16.46% | -31.83% | -31.83% | 19.60% |
| Income Before Tax | -16.19% | -5.90% | -19.91% | -19.91% | 24.60% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.19% | -5.90% | -19.91% | -19.91% | 24.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.19% | -5.90% | -19.91% | -19.91% | 24.60% |
| EBIT | 12.26% | 16.46% | -31.83% | -31.83% | 19.60% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -2.78% | 3.25% | -7.73% | -7.73% | 26.26% |
| Normalized Basic EPS | -4.57% | 3.65% | -5.09% | -5.09% | 30.88% |
| EPS Diluted | -2.78% | 3.25% | -7.73% | -7.73% | 26.26% |
| Normalized Diluted EPS | -4.57% | 3.65% | -5.09% | -5.09% | 30.88% |
| Average Basic Shares Outstanding | 11.19% | 11.09% | 10.23% | 10.23% | 9.30% |
| Average Diluted Shares Outstanding | 11.19% | 11.09% | 10.23% | 10.23% | 9.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |